🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today at #ASCO25, UNC Lineberger's Mya Roberson, MSPH, PhD, PhD, MSPH, is a panelist at the oral abstract session on Care Delivery and Quality Care: Too Many Rules, Too Many Traps: Can Policy Help Close the Gaps? This session is 1 - 4 p.m. CT in S504. unclineberger.org/news/unc-facul…

At #ASCO25, Kyle Lavin, MD, MPH, & Junlone Moy, PharmD, RPh, (w/Amber Cipriani, PharmD, BCOP) presented on enhancing patient QOL and mental health through collaborative care and bringing academic precision oncology to community settings, respectively. UNC Pharmacy

IKYMI: In today’s @NYTimes, Lisa Carey, MD, ScM, FASCO & Norman Sharpless Ned Sharpless shared insights on a blood test that detects DNA shed by metastatic breast cancer that is growing resistant to treatment. Carey: This could be “practice changing.” Sharpless: It “is really going to transform

At #ASCO25, Daniel Richardson discussed the development of a decision support tool (VOICE) for older adults with advanced cancer. Patients reported VOICE produced high-quality shared decision-making compared to an educational document with w/cancer-related question prompts.

At #ASCO25, Dr. Fumiko Chino shares findings from her research on cancer misinformation online. Hear how better understanding online information can help support patients and guide meaningful conversations in the clinic. #EndCancer Fumiko Ladd Chino, MD, FASCO

Today at #ASCO25, Paola Zagami, MD, will present at the oral abstract session on the impact of ovarian function suppression with adjuvant endocrine therapy on survival outcomes in young germline BRCA mutation carriers with breast cancer: Secondary analysis of an international

At #ASCO25, @YabdouMD reported Black pts with high-risk HR+/HER2 early breast cancer had higher recurrence risk + worse survival compared w/White pts, underscoring the urgent need to improve outcomes/address disparities. #BCSM

Excellent presentation by Paola Zagami, MD showing OFS + ET improved DFS and OS in a global cohort of young BRCA mutation carriers! Proud of you 👏🏼 👏🏼🤩 #ASCO25 #bcsm OncoAlert Matteo Lambertini, MD PhD

Oncologists are “losing the battle” against misinformation. The Times and The Sunday Times on #ASCO25 research presented ASCO including our work showing survivors worry about finding high quality cancer info online & that trust in science is at risk. 🙏✍️Poppy Koronka thetimes.com/uk/healthcare/…

Congrats to our faculty honored @ #ASCO25 🏆Lisa Carey, MD, ScM, FASCO> OncLive.com Giants of Cancer Award 🏆Ashley Ashley Leak Bryant PhD, RN, OCN, FAAN> Helio/ONS Advanced Practice Trailblazer Award 🏆UNC Lineberger e-PRO> Helio/City of Hope Clinical Innovation Award Ethan Basch HemOnc Today Oncology Nursing Society

🚀 Exciting News! 🚀 New video showcasing our innovative research is dropping soon. Stay tuned next week on the UNC School of Medicine website & social channels. 🌟 Dr. Jean Cook's lab members share insights into their vital work #BasicScienceResearch #CancerResearch #CellCycle Dalia Fleifel

#ASCO25 was a blast!

A combination treatment improves outcomes in colorectal cancer, and a blood test detects cancer years before symptoms appear. Read these stories and more in Cancer Today's Week in Cancer News.

📗Management of HCC CA: A Cancer Journal for Clinicians ✅ A review from diagnosis to treatments 👉doi.org/10.3322/caac.7… OncoAlert #cancer #Oncology #MedX #liver

🔬🧬🎙️There has never been a more important time to be an advocate for science and to speak effectively to a lay audience on why research matters. This JNCI 📄 covers the foundations of good health/science communication. Margot Sanger-Katz 👉academic.oup.com/jncimono/artic…

Source: jamanetwork.com/journals/jama/…

Now in Cancer Cell our group reports the development of a first-in-class EGFR-directed KRAS G12V selective inhibitor. KRAS G12V mutations are the 2nd most common KRAS mutation in cancer, and there are still no approved inhibitors in the clinic. We address two major challenges

Patient developed & recruited survey of people w #MBC IV #breastCancer on side effects from ADCs shows side effect burden is very high & dose reductions is COMMON. 👏 👏We need more research centered on the pt experience from new treatments. 👏👏 Dr Dr. Kelly Shanahan #mascc25

AACR Past President and #AACRFellows Dr. Elizabeth Jaffee, Association of American Cancer Institutes Past President and AACR member Dr. George Weiner, and #AACRFellows Dr. Steven Rosenberg spoke with CBS Sunday Morning 🌞 about the devastating impact of NIH cuts on cancer research. brnw.ch/21wTNt3

If you are a man diagnosed with breast cancer, know your options. You may qualify for the ETHAN trial if you have not yet had surgery. #knowledgeispower #changingthefaceofbreastcancer #breastcancerinmen Dana-Farber